Elevance Health, Inc.
US ˙ NYSE

SecurityELV / Elevance Health, Inc.
InstitutionCenterBook Partners LP
Latest Disclosed Ownership3,637 shares
Latest Disclosed Value $ 1,064,732
CenterBook Partners LP reports 70.49% decrease in ownership of ELV / Elevance Health, Inc.

On May 5, 2026 - CenterBook Partners LP filed a 13F-HR form disclosing ownership of 3,637 shares of Elevance Health, Inc. (US:ELV) valued at $1,064,732 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 12,323 shares of Elevance Health, Inc.. This represents a change in shares of -70.49% during the quarter. The current value of the position is $1,423,049 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 3,637 -8,686 -70.49 1,065 -75.36 0.0572
2026-02-11 2025-12-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 12,323 4,320
2025-11-07 2025-09-30 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 12,078 2,033 20.24 3,903 -0.13 0.1928
2025-08-12 2025-06-30 13F ELEVANCE HEALTH COM 036752103 10,045 7,223 255.95 3,907 218.42 0.2171
2025-05-09 2025-03-31 13F ELEVANCE HEALTH COM 036752103 2,822 -33,890 -92.31 1,227 -90.94 0.0782
2025-02-13 2024-12-31 13F ELEVANCE HEALTH COM 036752103 36,712 30,954 537.58 13,543 352.34 0.8091
2024-11-14 2024-09-30 13F ELEVANCE HEALTH COM 036752103 5,758 -2,071 -26.45 2,994 -29.42 0.1840
2024-08-12 2024-06-30 13F ELEVANCE HEALTH COM 036752103 7,829 7,829 4,242 0.2636
2023-05-15 2023-03-31 13F ELEVANCE HEALTH COM 036752103 0 -3,732 -100.00 0 -100.00
2023-02-13 2022-12-31 13F ELEVANCE HEALTH COM 036752103 3,732 1,000 36.60 1,914 54.23 0.3153
2022-11-14 2022-09-30 13F ELEVANCE HEALTH COM 036752103 2,732 1,348 97.40 1,241 85.78 0.2394
2022-08-15 2022-06-30 13F ELEVANCE HEALTH COM 036752103 1,384 261 23.24 668 21.01 0.1431
2022-05-16 2022-03-31 13F ANTHEM COM 036752103 1,123 685 156.39 552 171.92 0.1965
2022-02-11 2021-12-31 13F ANTHEM COM 036752103 438 438 203 0.1192
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.